Case Report
Case Reports That Illustrate the Efficacy of SGLT2 Inhibitors in the Type 1 Diabetic Patient
Table 1
Characteristics of type 1 diabetic patients before SGLT2 therapy.
| Patient | Age in years | Gender | Duration of diabetes (years) | eGFR mls/min | Total daily insulin dose and type |
| 1 | 33 | Female | 16 | 97 | Detemir 15 units | Lispro 10 units |
| 2 | 63 | Female | 23 | 64 | Glargine 40 units | Lispro 12 units |
| 3 | 68 | Male | 35 | 65 | Detemir 54 units | Aspart 10 units |
| 4 | 44 | Male | 26 | 42 | Glargine 80 units | Aspart 300 units |
| 5 | 42 | Female | 28 | 84 | Aspart 50 units by insulin pump |
|
|